10mgPurity Exceeds 99%
PT-141 10mg
PT-141 (Bremelanotide)
PT-141 (Bremelanotide) is the active metabolite of Melanotan II with selective action on central MC3R and MC4R receptors. Investigated in models of hypoactive sexual desire disorder in both male and female subjects.
For Research Use Only
Not for human consumption, veterinary use, or any therapeutic applications.
Purity
Purity Exceeds 99%
Storage
36-46°F (2-8°C)
Origin
Made in USA
Documentation
COA Available
Procurement Information
This product is available exclusively to qualified research institutions and licensed facilities through authorized distribution channels.
- Valid research credentials required
- Orders processed through authorized agents only
- End-user certification documentation required
Research Mechanisms
- Selective MC3R and MC4R central receptor agonist
- Central nervous system sexual arousal pathway activation
- Dopaminergic reward system modulation
- No direct vascular mechanism (unlike PDE5 inhibitors)
- Research in both male and female desire models
Research Background
- FDA approved as Vyleesi for HSDD in premenopausal women
- Studies on erectile dysfunction mechanisms
- Investigations into central sexual arousal pathways
- Research on melanocortin receptor pharmacology
Storage & Handling
Recommended Storage Conditions
Store at 36–46°F (2–8°C). Protect from light. Do not freeze.
- - Keep away from direct sunlight
- - Maintain consistent temperature
- - Check expiration date before use
- - Reconstituted peptides: use within 28 days